| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHRS | Coherus BioSciences, Inc. | Szela Mary T | Director | Jun 22, 2020 | Option Exercise | $13.21 | 109,994 | 1,452,659 | 54,997 | Jun 24, 2020, 04:55 PM | |
| NVLN | NOVELION THERAPEUTICS INC. | Szela Mary T | Chief Executive Officer | May 09, 2017 | Option Exercise | $9.42 | 2,248 | 21,176 | 4,384 | May 11, 2017, 04:02 PM | |
| ABT | ABBOTT LABORATORIES | Szela Mary T | Senior Vice President | Dec 14, 2011 | Sale | $54.01 | 106,402 | 5,746,628 | 172,543 | Dec 16, 2011, 06:23 PM | |
| ABT | ABBOTT LABORATORIES | Szela Mary T | Senior Vice President | Mar 31, 2011 | Sale | $48.69 | 31,920 | 1,554,089 | 135,302 | Apr 01, 2011, 05:05 PM | |
| ABT | ABBOTT LABORATORIES | Szela Mary T | Senior Vice President | Feb 28, 2011 | Option Exercise | $47.75 | 11,833 | 565,042 | 138,597 | Mar 02, 2011, 05:17 PM | |
| ABT | ABBOTT LABORATORIES | Szela Mary T | Senior Vice President | Mar 01, 2011 | Sale | $48.12 | 17,267 | 830,862 | 135,909 | Mar 02, 2011, 05:17 PM | |
| ABT | ABBOTT LABORATORIES | Szela Mary T | Senior Vice President | Aug 27, 2010 | Option Exercise | $49.50 | 1,815 | 89,843 | 126,442 | Aug 31, 2010, 05:19 PM |
Menu